Literature DB >> 19222651

Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.

Terence V McCann1, Eileen Clark, Sai Lu.   

Abstract

AIM: This paper is a report of a study conducted to describe the prevalence of antipsychotic medication side effects in individuals with schizophrenia, and to assess if a relationship existed between side effects and medication-taking.
BACKGROUND: Non-adherence to antipsychotics is common in people with schizophrenia. There is a direct relationship between non-adherence and relapse, but it is unclear if an association exists between side effects and non-adherence.
METHOD: The Liverpool University Neuroleptic Side-effect Rating Scale was used with a convenience sample of 81 mental health service users with schizophrenia. Participants were recruited from one urban and one rural area in Australia in 2004. Data were analysed using Statistical Package for Social Science and nonparametric statistical methods based on the nature of data.
FINDINGS: Around 20% of participants had missed taking their medication at least once in the week before data collection. About half experienced one or more side effects, but the level of accumulated side effects was not associated with medication omission. Older participants were more likely to experience anticholinergic and allergic side effects than their younger counterparts. Younger women were more likely to experience hormone-related side effects than older women. Overall, medication omission was not statistically significantly correlated with any of the seven Liverpool University Neuroleptic Side-effect Rating Scale subscales.
CONCLUSION: Greater attention needs to be paid to age- and gender-specific side effects and to monitoring side effects in people prescribed atypical medication antipsychotics. Service users, case managers and prescribers may need additional training to assist them to identify side effects and to take steps to ameliorate or at least minimize their effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222651     DOI: 10.1111/j.1365-2648.2008.04906.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  9 in total

1.  Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study.

Authors:  Merhawi Bahta; Tzeggai Berhe; Mulugeta Russom; Eyasu H Tesfamariam; Azieb Ogbaghebriel
Journal:  Integr Pharm Res Pract       Date:  2020-10-14

2.  Acceptance and Efficacy of Metacognitive Training (MCT) on Positive Symptoms and Delusions in Patients With Schizophrenia: A Meta-analysis Taking Into Account Important Moderators.

Authors:  Carolin Eichner; Fabrice Berna
Journal:  Schizophr Bull       Date:  2016-01-08       Impact factor: 9.306

3.  The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis.

Authors:  Maria Stella Calafato; Isabelle Austin-Zimmerman; Johan H Thygesen; Mani Sairam; Antonio Metastasio; Louise Marston; Francisco Abad-Santos; Anjali Bhat; Jasmine Harju-Seppänen; Haritz Irizar; Eirini Zartaloudi; Elvira Bramon
Journal:  Pharmacogenomics J       Date:  2020-02-04       Impact factor: 3.550

4.  Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review.

Authors:  Kyoko Higashi; Goran Medic; Kavi J Littlewood; Teresa Diez; Ola Granström; Marc De Hert
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

5.  Characteristics of voluntary reporting of adverse drug events related to antipsychotics in Australia: 14-year analysis.

Authors:  Hanan Khalil; Dimi Hoppe; Nabil Ameen
Journal:  Ther Adv Drug Saf       Date:  2021-05-29

Review 6.  Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.

Authors:  Peter M Haddad; Cecilia Brain; Jan Scott
Journal:  Patient Relat Outcome Meas       Date:  2014-06-23

Review 7.  Approaches to improve adherence to pharmacotherapy in patients with schizophrenia.

Authors:  Kimberly M Shuler
Journal:  Patient Prefer Adherence       Date:  2014-05-14       Impact factor: 2.711

8.  The Antipsychotic Medication Management Fidelity Scale: Psychometric properties.

Authors:  Torleif Ruud; Karin Drivenes; Robert E Drake; Vegard Øksendal Haaland; Matthew Landers; Bjørn Stensrud; Kristin S Heiervang; Lars Tanum; Gary R Bond
Journal:  Adm Policy Ment Health       Date:  2020-11

9.  Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study.

Authors:  Aya Ahmed Abousheishaa; Ahmad Hatim Sulaiman; Hasniza Zaman Huri; Siti Fatimah Binti Kamis; Hafizah Hamidi; Wei Chern Ang; Zainol Akbar Bin Zainal; Noorasyikin Shamsuddin; Ng Chong Guan
Journal:  BMC Health Serv Res       Date:  2022-03-09       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.